Back to User profile » Dr Dawn Velligan

Papers published by Dr Dawn Velligan:


Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic

Haider B, O'Sullivan AK, Bessonova L, Keane E, Achtyes E, Harvey PD, Kane JM, Saklad SR, Trotter JP, Claxton A, Polak T, McGrory J, Noori W, Sikora Kessler A, Yarlas A, Velligan D

Neuropsychiatric Disease and Treatment 2023, 19:623-634

Published Date: 17 March 2023

Patient and Provider Perspectives on Medication Non-adherence Among Patients with Depression and/or Diabetes in Diverse Community Settings – A Qualitative Analysis

Hamilton JE, Blanco E, Selek S, Wirfel KL, Bernstam EV, Velligan D, Gudala M, Roberts K

Patient Preference and Adherence 2022, 16:1581-1594

Published Date: 30 June 2022

Prescriber Attitudes, Experiences, and Proclivities Toward Digital Medicine and How They Influence Adoption of Digital Medicine Platforms

Ruetsch C, Davis T, Liberman JN, Velligan DI, Robinson D, Jaeger C, Carpenter W, Forma F

Neuropsychiatric Disease and Treatment 2021, 17:3715-3726

Published Date: 16 December 2021

Antipsychotic Treatment Experiences of People with Schizophrenia: Patient Perspectives from an Online Survey

Doane MJ, Sajatovic M, Weiden PJ, O’Sullivan AK, Maher S, Bjorner JB, Sikora Kessler A, Carpenter-Conlin J, Bessonova L, Velligan DI

Patient Preference and Adherence 2020, 14:2043-2054

Published Date: 28 October 2020

Engagement-focused care during transitions from inpatient and emergency psychiatric facilities

Velligan DI, Fredrick M, Sierra C, Hillner K, Kliewer J, Roberts DL, Mintz J

Patient Preference and Adherence 2017, 11:919-928

Published Date: 12 May 2017